If you have already secured personal funding, and would like to apply for a PhD at the William Harvey Research Institute, please see theresearch areaswhere we are able to offer projects.
Currently available PhD projects within the William Harvey Research Institute are also listed below.
Once you have identified an area of research or specific PhD project that interests you please contact the listed supervisor to discuss further.
If you wish to discuss PhD projects and research opportunities further please contactDr Dianne Cooper(Director of Graduate Studies).
Once you have identified a suitable project and supervisor please submit an online application where you should select the relevant William Harvey Research Institute course.
Current PhD projects
Application of traditional clinical and imaging risk assessment tools for ischaemic heart disease in BAME cohorts and development of ethnic specific tools (Professor Steffen Petersen, Professor Patricia Munroe)
Augmentation of cardiac macrophages for the treatment of heart failure (Professor Ken Suzuki)
Deciphering the role of PI3K signalling in dendritic cell antigen presentationfunctions and adaptive immunity (Dr Ezra Aksoy)
Determining Pharmacogenetic Influences of Response to Antihypertensives and Statins Treatment using Clinical Trials and Large Biobanks (Dr Helen Warren, supervisor and Professor Patricia Munroe co-supervisor)
Development of a novel strategy of adult stem cell therapy for heart failure (Professor Ken Suzuki)
Development of an innovative approach for ESC/IPSC therapy for heart failure (Professor Ken Suzuki)
Development of an innovative extracellular vesicle-based therapy for heart failure (Professor Ken Suzuki)
Development of a new strategy for prevention of post-operative adhesion (Professor Ken Suzuki)
Evaluating the impact of metabolic regulation on iPSC-cardiomyogenic maturation (Dr Fiona Lewis-McDougall)
Exploring the molecular mechanisms of PI3K alpha - RAS signalling in amino acids sensing mTORC1 pathway in intestinal epithelial homeostasis (Dr Ezra Aksoy)
Proteomics based druggable target discovery in cardiovascular diseases (Dr Vahitha Abdul Salam)
Prospective observational study investigating genomic determinants of outcome from cardiogenic shock (GOlDilOCS) (Dr Alastair Proudfoot, (CI), Professor Charles Hinds (PI), J Knight (PI), T Gerschlick (PI) )
Role of melanocortin receptor accessory proteins in adrenal function and metabolism (Dr Li Chan)
Study of heart diseases using artificial intelligence (AI) with cardiovascular magnetic resonance (CMR) and electronic health record (HER) data in the Barts BioResource (Professor Steffen Petersen)